Base de dados : MEDLINE
Pesquisa : N03.219.463.085 [Categoria DeCS]
Referências encontradas : 3820 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 382 ir para página                         

  1 / 3820 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29208605
[Au] Autor:Bagcchi S
[Ad] Endereço:Kolkata, India.
[Ti] Título:Progress on malaria stalls amid decline in funding.
[So] Source:BMJ;359:j5645, 2017 12 05.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Financiamento de Capital
Malária/economia
Malária/prevenção & controle
Programas Nacionais de Saúde/economia
[Mh] Termos MeSH secundário: Saúde Global
Seres Humanos
Incidência
[Pt] Tipo de publicação:NEWS
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180222
[Lr] Data última revisão:
180222
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171207
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.j5645


  2 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29239578
[Au] Autor:Salo H; Kilpi T
[Ti] Título:National vaccination program - a success story of public health and economy.
[So] Source:Duodecim;133(10):977-83, 2017.
[Is] ISSN:0012-7183
[Cp] País de publicação:Finland
[La] Idioma:eng
[Ab] Resumo:The savings in treatment costs generated by disease cases prevented by the national vaccination program exceed the costs of the vaccination program by at least 60 million euros. In addition, other costs due to contracting the illness are avoided. Vaccinations serve the purpose of both increasing well-being and releasing resources for other uses. Financial support of vaccinations through the health insurance system would be costly and targetted to those with the ability to pay. Public funds should be directed to the development of a vaccination program. New vaccines coming on the market are expensive. Adding a new vaccine to the vaccination program is based on scientific evidence-based expert assessments and cost-effectiveness. In addition to preliminary assessments carried out in support of decision-making, the National Institute of Health and Welfare monitors by using population-based health registers the effectiveness and cost-effectiveness of the vaccination program. From the standpoint of transparency of decision-making it would be preferred that the decision-makers define a willingness to pay threshold below which an intervention would be accepted and lead to funding.
[Mh] Termos MeSH primário: Programas de Imunização/economia
Saúde Pública/economia
[Mh] Termos MeSH secundário: Financiamento de Capital
Análise Custo-Benefício
Tomada de Decisões
Finlândia
Política de Saúde
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180115
[Lr] Data última revisão:
180115
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171215
[St] Status:MEDLINE


  3 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29232385
[Au] Autor:Fitzpatrick A; Al-Kobaisi NSMS; Beitman Maya J; Ren Chung Y; Duhan S; Elbegdorj E; Jain S; Kuhn E; Nastase A; Ahmed BN; Olliaro P
[Ad] Endereço:Blavatnik School of Government, University of Oxford, Oxford, United Kingdom.
[Ti] Título:Sustaining visceral leishmaniasis elimination in Bangladesh - Could a policy brief help?
[So] Source:PLoS Negl Trop Dis;11(12):e0006081, 2017 Dec.
[Is] ISSN:1935-2735
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Bangladesh has made significant progress towards elimination of visceral leishmaniasis, and is on track to achieve its target of less than one case per 10,000 inhabitants in each subdistrict in 2017. As the incidence of disease falls, it is likely that the political capital and financial resources dedicated towards the elimination of visceral leishmaniasis may decrease, raising the prospect of disease resurgence. Policy memos may play a crucial role during the transition of the elimination plan from the 'attack' to the 'consolidation' and 'maintenance' phases, highlighting key stakeholders and areas where ongoing investment is crucial. An example of a policy brief is outlined in this paper. The background to the current elimination efforts is highlighted, with emphasis on remaining uncertainties including the impact of disease reservoirs and sustainable surveillance strategies. A stakeholder map is provided outlining the current and projected future activities of key bodies. Identification of key stakeholders subsequently frames the discussion of three key policy recommendations in the Bangladeshi context for the transition to the consolidation and maintenance phases of the elimination program. Recommendations include determining optimal vector control and surveillance strategies, shifting the emphasis towards horizontal integration of disease programs, and prioritising remaining research questions with a focus on operational and technical capacity. Achieving elimination is as much a political as a scientific question. Integrating the discussion of key stakeholders with policy priorities and the research agenda provides a novel insight into potential pathways forwards in the elimination of visceral leishmaniasis in Bangladesh and in the rest of the Indian subcontinent.
[Mh] Termos MeSH primário: Controle de Doenças Transmissíveis/organização & administração
Erradicação de Doenças/organização & administração
Leishmaniose Visceral/epidemiologia
Leishmaniose Visceral/prevenção & controle
[Mh] Termos MeSH secundário: Bangladesh/epidemiologia
Financiamento de Capital
Monitoramento Epidemiológico
Política de Saúde
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171224
[Lr] Data última revisão:
171224
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171213
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pntd.0006081


  4 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28933939
[Au] Autor:Grundy Q; Held F; Bero L
[Ad] Endereço:Quinn Grundy and Lisa Bero are with the Faculty of Pharmacy and Fabian Held is with the Faculty of Science, the Charles Perkins Centre, The University of Sydney, Sydney, Australia.
[Ti] Título:A Social Network Analysis of the Financial Links Backing Health and Fitness Apps.
[So] Source:Am J Public Health;107(11):1783-1788, 2017 Nov.
[Is] ISSN:1541-0048
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: To identify the major stakeholders in mobile health app development and to describe their financial relationships using social network analysis. METHODS: We conducted a structured content analysis of a purposive sample of prominent health and fitness apps available in November 2015 in the United States, Canada, and Australia. We conducted a social network analysis of apps' developers, investors, other funding sources, and content advisors to describe the financial relationships underpinning health app development. RESULTS: Prominent health and fitness apps are largely developed by private companies based in North America, with an average of 4.7 (SD = 5.5) financial relations, including founders, external investors, acquiring companies, and commercial partnerships. Network analysis revealed a core of 41 sampled apps connected to 415 other entities by 466 financial relations. This core largely comprised apps published by major technology, pharmaceutical, and fashion corporations. About one third of apps named advisors, many of whom had commercial affiliations. CONCLUSIONS: Public health needs to extend its scrutiny and advocacy beyond the health messages contained within apps to understanding commercial influences on health and, when necessary, challenging them.
[Mh] Termos MeSH primário: Financiamento de Capital
Comércio
Aplicativos Móveis
Apoio Social
[Mh] Termos MeSH secundário: Austrália
Canadá
Financiamento de Capital/economia
Financiamento de Capital/organização & administração
Comércio/economia
Comércio/organização & administração
Indústria Farmacêutica
Seres Humanos
Indústrias/economia
Indústrias/organização & administração
Aplicativos Móveis/economia
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171025
[Lr] Data última revisão:
171025
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170922
[St] Status:MEDLINE
[do] DOI:10.2105/AJPH.2017.303995


  5 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28853306
[Au] Autor:Komenkul K; Kiranand S
[Ad] Endereço:1 Rangsit University, Pathum Thani, Thailand.
[Ti] Título:Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries.
[So] Source:Inquiry;54:46958017727105, 2017 Jan 01.
[Is] ISSN:1945-7243
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:We examine the evidence from the long-run abnormal returns using data for 76 health care and biopharmaceutical initial public offerings (IPOs) listed in a 29-year period between 1986 and 2014 in the Association of Southeast Asian Nations (ASEAN) countries such as Indonesia, Malaysia, Singapore, Thailand, the Philippines, Vietnam, Myanmar, and Laos. Based on the event-time approach, the 3-year stock returns of the IPOs are investigated using cumulative abnormal return (CAR) and buy-and-hold abnormal return (BHAR). As a robustness check, the calendar-time approach, related to the market model as well as Fama-French and Carhart models, was applied for verifying long-run abnormal returns. We found evidence that the health care IPOs overperform in the long-run, irrespective of the alternative benchmarks and methods. In addition, when we divide our sample into 5 groups by listing countries, our results show that the health care stock prices of the Singaporean firms behaved differently from those of most of the other firms in ASEAN. The Singaporean IPOs are characterized by a worse post-offering performance, whereas the IPOs of Malaysian and Thai health care companies performed better in the long-run.
[Mh] Termos MeSH primário: Indústria Farmacêutica/economia
Contrato de Risco
Setor de Assistência à Saúde/estatística & dados numéricos
Investimentos em Saúde/estatística & dados numéricos
[Mh] Termos MeSH secundário: Ásia Sudeste
Biotecnologia
Financiamento de Capital/economia
Seres Humanos
Investimentos em Saúde/economia
Setor Privado/economia
Fatores de Tempo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170911
[Lr] Data última revisão:
170911
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170831
[St] Status:MEDLINE
[do] DOI:10.1177/0046958017727105


  6 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28816904
[Au] Autor:Hegde V; Johansen D; Park HY; Zoller SD; Hamad C; Bernthal NM
[Ad] Endereço:1Department of Orthopaedic Surgery, David Geffen School of Medicine at the University of California Los Angeles, Santa Monica, California.
[Ti] Título:The Relationship Between OREF Grants and Future NIH Funding Success.
[So] Source:J Bone Joint Surg Am;99(16):e87, 2017 Aug 16.
[Is] ISSN:1535-1386
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The Orthopaedic Research and Education Foundation (OREF) is the leading specialty-specific nongovernmental organization providing orthopaedic funding in the United States. As extramural research funding has become increasingly difficult to acquire, one mission of the OREF is to support investigators to generate data needed to secure larger extramural funding from agencies such as the National Institutes of Health (NIH). The objectives of this study were to evaluate the rate of translating OREF faculty-level grants into subsequent NIH funding and to determine if there are identifiable factors that increase the rate of converting an OREF grant into NIH funding. METHODS: This is a retrospective review of OREF grants awarded to full-time faculty orthopaedic surgeons between 1994 and 2014. Grants were analyzed on the basis of award type and were categorized as basic science, clinical, or epidemiological. Sex, individual scholarly productivity, and publication experience were evaluated. All awardees were assessed for subsequent NIH funding using the NIH RePORTER web site. RESULTS: One hundred and twenty-six faculty-level OREF grants were awarded to 121 individuals. Twenty-seven OREF grant awardees (22%) received NIH funding at a mean of 6.3 years after OREF funding. Nineteen (46%) of 41 Career Development Grant winners later received NIH funding compared with 10 (12%) of 85 other award winners. OREF grants for basic science projects were awarded more often (58%) and were more than 4 times as likely to result in NIH funding than non-basic science projects (odds ratio, 4.70 [95% confidence interval, 1.66 to 13.33]; p = 0.0036). Faculty who later received NIH funding had higher scholarly productivity and publication experience (p < 0.05). CONCLUSIONS: The OREF grant awardee conversion rate of 22% and, particularly, the 46% for Career Development Grant winners compares favorably with the overall NIH funding success rate (18% in 2014). Faculty-level OREF grants appear to achieve their purpose of identifying and supporting researchers who aim to secure subsequent federal funding. CLINICAL RELEVANCE: The goal of this study is to examine how successful faculty who have obtained OREF grants have been in securing NIH funding later in their careers. Although subsequent accrual of NIH funding is not the only goal of OREF funding, it can be used as an important benchmark to assess the development of orthopaedic clinician-scientists.
[Mh] Termos MeSH primário: Pesquisa Biomédica/economia
Financiamento de Capital/organização & administração
Organização do Financiamento
National Institutes of Health (U.S.)/economia
Ortopedia/economia
Apoio à Pesquisa como Assunto/economia
[Mh] Termos MeSH secundário: Fundações/economia
Seres Humanos
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170908
[Lr] Data última revisão:
170908
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170818
[St] Status:MEDLINE
[do] DOI:10.2106/JBJS.16.01278


  7 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28617202
[Au] Autor:Choi S
[Ad] Endereço:1 University of Minnesota School of Public Health, Minneapolis, MN, USA.
[Ti] Título:Hospital Capital Investment During the Great Recession.
[So] Source:Inquiry;54:46958017708399, 2017 Jan 01.
[Is] ISSN:1945-7243
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Hospital capital investment is important for acquiring and maintaining technology and equipment needed to provide health care. Reduction in capital investment by a hospital has negative implications for patient outcomes. Most hospitals rely on debt and internal cash flow to fund capital investment. The great recession may have made it difficult for hospitals to borrow, thus reducing their capital investment. I investigated the impact of the great recession on capital investment made by California hospitals. Modeling how hospital capital investment may have been liquidity constrained during the recession is a novel contribution to the literature. I estimated the model with California Office of Statewide Health Planning and Development data and system generalized method of moments. Findings suggest that not-for-profit and public hospitals were liquidity constrained during the recession. Comparing the changes in hospital capital investment between 2006 and 2009 showed that hospitals used cash flow to increase capital investment by $2.45 million, other things equal.
[Mh] Termos MeSH primário: Financiamento de Capital/tendências
Recessão Econômica
Administração Financeira de Hospitais/organização & administração
Investimentos em Saúde
[Mh] Termos MeSH secundário: California
Bases de Dados Factuais
Administração Financeira de Hospitais/estatística & dados numéricos
Modelos Teóricos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170713
[Lr] Data última revisão:
170713
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170616
[St] Status:MEDLINE
[do] DOI:10.1177/0046958017708399


  8 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28411933
[Au] Autor:Millin MG; Hawkins SC
[Ad] Endereço:Department of Emergency Medicine, Johns Hopkins University School of Medicine, Maryland Search and Rescue, 5801 Smith Avenue, Davis Building, Suite 3220, Baltimore, MD 21209, USA. Electronic address: MichaelGMillin@gmail.com.
[Ti] Título:Wilderness Emergency Medical Services Systems.
[So] Source:Emerg Med Clin North Am;35(2):377-389, 2017 May.
[Is] ISSN:1558-0539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Wilderness emergency medical services (WEMS) are designed to provide high quality health care in wilderness environments. A WEMS program should have oversight by a qualified physician responsible for protocol development, education, and quality improvement. The director is also ideally fully trained as a member of that wilderness rescue program, supporting the team with real-time patient care. WEMS providers function with scopes of practice approved by the local medical director and regulatory authority. With a focus on providing quality patient care, it is time for the evolution of WEMS as an integrated element of a local emergency response system.
[Mh] Termos MeSH primário: Serviços Médicos de Emergência/organização & administração
Meio Selvagem
[Mh] Termos MeSH secundário: Financiamento de Capital
Serviços Médicos de Emergência/economia
Serviços Médicos de Emergência/história
Serviços Médicos de Emergência/legislação & jurisprudência
Equipamentos e Provisões
História do Século XX
Seres Humanos
Responsabilidade Legal
Estados Unidos
[Pt] Tipo de publicação:HISTORICAL ARTICLE; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170421
[Lr] Data última revisão:
170421
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170417
[St] Status:MEDLINE


  9 / 3820 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28357943
[Ti] Título:Chancellor allocates extra funds for STPs.
[So] Source:Nurs Manag (Harrow);24(1):6, 2017 Mar 30.
[Is] ISSN:1354-5760
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Additional funds for sustainability and transformation plans (STPs) were announced in the spring budget.
[Mh] Termos MeSH primário: Medicina Estatal/economia
[Mh] Termos MeSH secundário: Financiamento de Capital
Reino Unido
[Pt] Tipo de publicação:NEWS
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170622
[Lr] Data última revisão:
170622
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170331
[St] Status:MEDLINE
[do] DOI:10.7748/nm.24.1.6.s3


  10 / 3820 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28320729
[Au] Autor:Limb M
[Ad] Endereço:London.
[Ti] Título:Croydon CCG stops funding IVF treatment to save £800 000 a year.
[So] Source:BMJ;356:j1403, 2017 03 20.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Financiamento de Capital/economia
Fertilização In Vitro/economia
[Mh] Termos MeSH secundário: Inglaterra
Seres Humanos
Medicina Estatal
[Pt] Tipo de publicação:NEWS
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171109
[Lr] Data última revisão:
171109
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170322
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.j1403



página 1 de 382 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde